Real-world comparison of chemo-immunotherapy and chemotherapy alone in the treatment of extensive-stage small-cell lung cancer
-
Published:2024-11
Issue:
Volume:86
Page:101125
-
ISSN:2590-0412
-
Container-title:Respiratory Medicine and Research
-
language:en
-
Short-container-title:Respiratory Medicine and Research
Author:
Lamy Déborah,
Mouillot Pierre,
Mariet Anne-Sophie,
Barnestein Robby,
Quilot Fleur-Marie,
Fraisse Cléa,
Ghiringhelli François,
Bonniaud PhilippeORCID,
Zouak Ayoube,
Foucher Pascal
Reference35 articles.
1. Small-cell lung cancer;Rudin;Nat Rev Dis Primer,2021
2. Small cell lung cancer patients treated with immune checkpoint inhibitor: a systematic literature review of treatment efficacy, safety and quality of life;Korde;Curr Med Res Opin,2022
3. Update 2021: management of small cell lung cancer;Tariq;Lung,2021
4. Changing epidemiology of small-cell lung cancer in the united states over the last 30 years: analysis of the surveillance, epidemiologic, and end results database;Govindan;JCO.,2006
5. Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial;Baize;Lancet Oncol,2020